Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Lumbar Spine Bone Loss Linked to Glucocorticoid Treatment
May 2026
Low-dose glucocorticoid treatment caused modest lumbar spine bone loss in rheumatoid arthritis over two years, a meta-analysis finds.
Read more
11 May 2026
Lumbar Spine Bone Loss Linked to Glucocorticoid Treatment
Low-dose glucocorticoid treatment caused modest lumbar spine bone loss in rheumatoid arthritis over two years, a meta-analysis finds.
8 May 2026
Understanding Postpartum Flares in Rheumatoid Arthritis
Researchers found higher rates of postpartum flare in rheumatoid arthritis, compared to stable disease activity in spondyloarthritis patients.
7 May 2026
Sex-Specific Genes Identified in Systemic Sclerosis
Researchers have identified sex-specific genetic risk factors in systemic sclerosis, revealing new pathways and potential treatment targets.
4 May 2026
Obinutuzumab Delivers Breakthrough in Lupus Control
Large phase 3 trial involving over 300 patients with active lupus, those treated with obinutuzumab achieved markedly higher response rates at one year. Nearly 77% of patients receiving the therapy met the primary endpoint
4 May 2026
Rheumatoid Arthritis Raises Risk of Cognitive Impairment
Large cohort study finds increased cognitive impairment risk in rheumatoid arthritis, supporting routine cognitive screening in clinical care.
2 May 2026
How the Gut Microbiota Shapes Lupus Activity
Discover how gut microbiota alterations may drive lupus progression, influence immune responses, and shape treatment outcomes in autoimmune disease.
29 Apr 2026
Incentive Programme Boosts Activity in Knee Osteoarthritis
Behavioural incentives increase daily steps in knee osteoarthritis, but neither incentives nor corticosteroid injections improve symptoms in clinical trial findings.
23 Apr 2026
Aspirin Cuts Cardiovascular Risk in Giant Cell Arteritis
Low-dose aspirin reduces cardiovascular risk in giant cell arteritis but increases bleeding risk, highlighting a complex clinical trade-off.
Loading posts...
1
2
3
…
43
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View